Novo Nordisk A S (NVO) Net Income towards Common Stockholders (2012 - 2016)

Novo Nordisk A S (NVO) has 5 years of Net Income towards Common Stockholders data on file, last reported at $1.5 billion in Q2 2016.

• Quarterly Net Income towards Common Stockholders rose 22.75% year-over-year to $1.5 billion in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $5.4 billion (up 8.05% YoY) and the FY2019 annual result came in at $178.1 billion, up 12.71% from the prior year.
• Net Income towards Common Stockholders rose to $1.5 billion in Q2 2016, from $1.4 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.5 billion in Q2 2013 to a low of $1.1 billion in Q1 2012.
• A 5-year average of $1.3 billion and a median of $1.3 billion in 2014 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2013 — Net Income towards Common Stockholders gained 28.75% — and 2014, when it slipped 23.35%.
• Tracing NVO's Net Income towards Common Stockholders over 5 years: stood at $1.3 billion in 2012, then advanced by 9.81% to $1.4 billion in 2013, then fell by 23.35% to $1.1 billion in 2014, then rose by 11.01% to $1.2 billion in 2015, then rose by 24.88% to $1.5 billion in 2016.
• The last three Net Income towards Common Stockholders figures came in at $1.5 billion (Q2 2016), $1.4 billion (Q1 2016), and $1.2 billion (Q4 2015), per Business Quant data.